D L Carlson Investment Group Inc Crispr Therapeutics Ag Transaction History

D L Carlson Investment Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$100.84 - $161.89 $3.73 Million - $5.99 Million	-37,012 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$110.72 - $210.04 $268,828 - $509,977	-2,428 Reduced 6.16%	37,012 $4.51 Million
Q4 2020 Feb 09, 2021	SELL	$79.67 - $173.23 $690,181 - $1.5 Million	-8,663 Reduced 18.01%	39,440 $6.04 Million
Q3 2020 Nov 13, 2020	BUY	$78.5 - $100.64 $1.68 Million - $2.16 Million	21,458 Added 80.53%	48,103 $4.02 Million
Q2 2020 Aug 13, 2020	BUY	$38.5 - $76.05 $1.03 Million - $2.03 Million	26,645 New	26,645 $1.96 Million

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of D L Carlson Investment Group Inc, based on Form 13F filings with the SEC.

Stay updated on D L Carlson Investment Group Inc with notifications on news.